Advertisement

CRP: Historical Perspective, Structure, Evolution, Synthesis, Clinical and Biological Functions

  • Waliza Ansar
  • Shyamasree Ghosh
Chapter

Abstract

The C-reactive protein (CRP) is a plasma protein belonging to pentraxin family and has hepatic origin. It is the chief component of any inflammatory reaction. A key mediator of the innate immune system, an inflammatory biomarker whose concentration rapidly increases to nearly or more than 1000-folds above the normal values during tissue injury or infection. CRP functions through interaction of components of both humoral and cellular effector mechanisms of inflammation. Although considered as an acute-phase protein in tissue injury, infection and inflammation has now attained a distinct status of inflammatory disease marker not only in cardiovascular diseases but has well-known clinical and pathological relevance. The present study encompassing a number of diseases and associated conditions has highly illuminated the research field with the therapeutic role of CRP in health and disease. The future prospect of this chapter lies in the monitoring and understanding the applicability of CRP in the biology of various diseases.

Keywords

C-reactive protein Disease Acute phase protein Evolution History Biology 

References

  1. Abernethy TJ, Avery OT (1941) The occurrence during acute infections of a protein not normally present in the blood. 1. Distribution of the reactive protein in patient’s sera and the effect of calcium on the flocculation reaction with C polysaccharide of Pneumococcus. J Exp Med 73:173–182CrossRefPubMedPubMedCentralGoogle Scholar
  2. Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE (2001) Topology and structure of the C1q-binding site on C-reactive protein. J Immunol 166:3998–4004CrossRefPubMedGoogle Scholar
  3. Ansar W, Habib SK, Roy S, Mandal C, Mandal C (2009a) Unraveling the C-reactive protein complement-cascade in destruction of red blood cells: potential pathological implications in Plasmodium falciparum malaria. Cell Physiol Biochem 23(1–3):175–190. doi: 10.1159/000204106. Epub 2009 Feb 18CrossRefPubMedGoogle Scholar
  4. Ansar W, Mukhopadhyay S, Habib SK, Basu S, Saha B, Sen AK, Mandal CN, Mandal C (2009b) Disease-associated glycosylated molecular variants of human C-reactive protein activate complement-mediated hemolysis of erythrocytes in tuberculosis and Indian visceral leishmaniasis. Glycoconj J 26(9):1151–69. doi: 10.1007/s10719-009-9236-y CrossRefPubMedGoogle Scholar
  5. Cid MC, Grant DS, Hoffman GS, Auerbach R, Fauci AS, Kleinman HK (1993) Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 91:977–985CrossRefPubMedPubMedCentralGoogle Scholar
  6. Clyne B, Olshaker JS (1999) The C-reactive protein. J Emerg Med 17:1019–1025CrossRefPubMedGoogle Scholar
  7. Culley FJ, Harris RA, Kaye PM, McAdam PWJ, Raynes JG (1996) C-reactive protein binds to a novel ligand on Leishmania donovani and increases uptake into human macrophages. J Immunol 156(12):4691–4696PubMedGoogle Scholar
  8. Culley FJ, Bodman-Smith KB, Ferguson MAJ, Nikolaev AV, Shantilal N, Raynes JG (2000) C-reactive protein binds to phosphorylated carbohydrates. Glycobiology 10(1):59–65, And references thereinCrossRefPubMedGoogle Scholar
  9. Das UN (2001) Is obesity an inflammatory condition? Nutrition 17:953–966CrossRefPubMedGoogle Scholar
  10. Das T, Sen A, Kempf T, Pramanik SR, Mandal C, Mandal C (2003) Induction of glycosylation in human C-reactive protein under different pathological conditions. Biochem J 373(Pt 2):345–355CrossRefPubMedPubMedCentralGoogle Scholar
  11. Das T, Mandal C, Mandal C (2004a) Variations in binding characteristics of glycosylated human C-reactive proteins in different pathological conditions. Glycoconj J 20(9):537–543CrossRefPubMedGoogle Scholar
  12. Das T, Mandal C, Mandal C (2004b) Protein A-a new ligand for human C-reactive protein. FEBS Lett 576:107–113CrossRefPubMedGoogle Scholar
  13. De Beer FC, Shine B, Pepys MB (1982a) Radiometric ligand binding assay for C-reactive protein. Complexed C reactive protein is not detectable in acute-phase serum. Clin Exp Immunol 50:231–237PubMedPubMedCentralGoogle Scholar
  14. De Beer FC, Hind CR, Fox KM, Allan RM, Maseri A, Pepys MB (1982b) Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J 47:239–243CrossRefPubMedPubMedCentralGoogle Scholar
  15. DiCamelli R, Potempa LA, Siegel L, Suyehira L, Petras K, Gewurz H (1980) Binding reactivity of C-reactive protein for polycations. J Immunol 125:1933–1938PubMedGoogle Scholar
  16. Dong Q, Wright JR (1996) Expression of C-reactive protein by alveolar macrophages. J Immunol 156:4815–4820PubMedGoogle Scholar
  17. Du Clos TW (1989) C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J Immunol 143:2553–2559PubMedGoogle Scholar
  18. Du Clos TW, Zlock LT, Rubin RL (1988) Analysis of the binding of C-reactive protein to histones and chromatin. J Immunol 141:4266–4270PubMedGoogle Scholar
  19. Fu T, Borensztajn J (2002) Macrophage uptake of low-density lipoprotein bound to aggregated C-reactive protein: possible mechanism of foam-cell formation in atherosclerotic lesions. Biochem J 366:195–201CrossRefPubMedPubMedCentralGoogle Scholar
  20. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340:448–454CrossRefPubMedGoogle Scholar
  21. Gasim S, Theander TG, ElHassan AM (2000) High levels of C-reactive protein in the peripheral blood during visceral leishmaniasis predict subsequent development of post kala-azar dermal leishmaniasis. Acta Trop 75(1):35–38CrossRefPubMedGoogle Scholar
  22. Gershov D, Kim S, Brot N, Elkon KB (2000) C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response: implications for systemic autoimmunity. J Exp Med 192:1353–1363CrossRefPubMedPubMedCentralGoogle Scholar
  23. Gould JM, Weiser JN (2001) Expression of C-reactive protein in the human respiratory tract. Infect Immun 69:1747–1754CrossRefPubMedPubMedCentralGoogle Scholar
  24. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB (1997) Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349:462–466CrossRefPubMedGoogle Scholar
  25. Hokama Y, Nakamura RM (1987) C-reactive protein – current status and future perspectives. J Clin Lab Anal 1:15–27CrossRefGoogle Scholar
  26. Hurlimann J, Thorbecke GJ, Hochwald GM (1966) The liver as the site of C-reactive protein formation. J Exp Med 123:365–378CrossRefPubMedPubMedCentralGoogle Scholar
  27. Hutchinson WL, Noble GE, Hawkins PN, Pepys MB (1994) The pentraxin, C-reactive protein and serum amyloid P component, are cleared and catabolized by hepatocytes in vivo. J Clin Invest 94:1390–1396CrossRefPubMedPubMedCentralGoogle Scholar
  28. Iwaki D, Osaki T, Mizunoe Y, Wai SN, Iwanaga S, S K (1999) Functional and structural diversities of C-reactive proteins present in horseshoe crab hemolymph plasma. Eur J Biochem 264(2):314–326CrossRefPubMedGoogle Scholar
  29. Jabs WJ, Logering BA, Gerke P, Kreft B, Wolber EM, Klinger MH et al (2003) The kidney as a second site of human C-reactive protein formation in vivo. Eur J Immunol 33:152–161CrossRefPubMedGoogle Scholar
  30. Kaplan MH, Volanakis JE (1974) Interactions of C-reactive protein complexes with the complement system, I: consumption of human complement associated with the reaction of C-reactive protein with pneumococcal C-polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J Immunol 112:2135–2147PubMedGoogle Scholar
  31. Kindmark CO (1971) Stimulating effect of C-reactive protein on phagocytosis of various species of pathogenic bacteria. Clin Exp Immunol 8:941–948PubMedPubMedCentralGoogle Scholar
  32. Kottgen E, Hell B, Kage A, Tauber R (1992) Lectin specificity and binding characteristics of human C-reactive protein. J Immunol 149:445–453PubMedGoogle Scholar
  33. Kushner I (1988) The acute phase response: An overview. Meths in Enzymol 163:373–383CrossRefGoogle Scholar
  34. Lasson A, Göransson J (1999) No microheterogenous changes of plasma C-reactive protein found in man during various diseases. Scand J Clin Lab Invest 59(4):293–304CrossRefPubMedGoogle Scholar
  35. Lee RT, Takagahara I, Lee YC (2002) Mapping the binding areas of human C-reactive protein for phosphocholine and polycationic compounds. Relationship between the two types of binding sites. J Biol Chem 277:225–232CrossRefPubMedGoogle Scholar
  36. Lei KJ, Liu T, Zon G, Soravia E, Liu T-Y, Goldman ND (1985) Genomic DNA sequence for human C-reactive protein. J Biol Chem 260:13377–13383PubMedGoogle Scholar
  37. Li P, Mold C, Du Clos TW (1994) Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. J Immunol 152(6):2995–3005PubMedGoogle Scholar
  38. Macintyre SS (1988) C-reactive protein. Meths in Enzymol 163:383–399CrossRefGoogle Scholar
  39. Macintyre SS, Kushner I, Samols D (1985) Secretion of C-reactive protein becomes more efficient during the course of the acute phase response. J Biol Chem 1985(260):4169–4173Google Scholar
  40. Macintyre SS, Samols D, Dailey P (1994) Two carboxylesterases bind C-reactive protein within the endoplasmic reticulum and regulate its secretion during the acute phase response. J Biol Chem 269:24496–24503PubMedGoogle Scholar
  41. Maclyn. Historical Perspective on C-Reactive Protein Annals of the New York Academy of Sciences 2006. Volume 389. C-Reactive Protein and the Plasma Protein Response to Tissue Injury, pp 1–479. WileyGoogle Scholar
  42. Marnell LL, Mold C, Volzer MA, Burlingame RW, Du Clos TW (1995) C-reactive protein binds to FcYRI in transfected COS cells. J Immunol 155:2185–2193PubMedGoogle Scholar
  43. McCarty MF (2004) Ampk activation may suppress hepatic production of C-reactive protein by nitric oxide synthetase. Med Hypotheses 63:328–333CrossRefPubMedGoogle Scholar
  44. Mold C, Rodgers CP, Richards RL, Alving CR, Gewurz H (1981) Interaction of C-reactive protein with liposomes. J Immunol 126:856–860PubMedGoogle Scholar
  45. Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann N Y Acad Sci 389:406–418CrossRefPubMedGoogle Scholar
  46. Munford RS (2001) Statins and the acute-phase response. N Engl J Med 344:2016–2018CrossRefPubMedGoogle Scholar
  47. Nagpurkar A, Mookerjea S (1981) A novel phosphorylcholine-binding protein from rat serum and its effect on heparin-lipoprotein complex formation in the presence of calcium. J Biol Chem 256:7440–7448PubMedGoogle Scholar
  48. Oliveira EB, Gotschlich EC, Liu T-Y (1979) Primary structure of human C-reactive protein. J Biol Chem 254(2):489–502PubMedGoogle Scholar
  49. Osmand AP, Friedenson B, Gewurz H, Painter RH, Hofmann T, Shelton E (1977) Characterization of C-reactive protein and the complement subcomponent C1t as homologous proteins displaying cyclic pentameric symmetry (pentraxins). Proc Nat Acad Sci USA 74:739–743CrossRefPubMedPubMedCentralGoogle Scholar
  50. Paul I, Mandal C, Mandal C (1998) Effect of environmental pollutants on the C-reactive protein of a freshwater major carp, Catla catla. Dev Comp Immunol 22(5–6):519–532CrossRefPubMedGoogle Scholar
  51. Paul I, Mandal C, Allen AK, Mandal C (2001) Molecular variants of C-reactive proteins from the major carp Catla catla in fresh and polluted aquatic environments. Glycoconjugate J 18:547–556CrossRefGoogle Scholar
  52. Pepys MB, Dash AC, Fletcher TC, Richardson N, Munn EA (1978) Analogues in other mammals and fish of human plasma proteins C-reactive protein and amyloid P component. Nature 273:168–170CrossRefPubMedGoogle Scholar
  53. Pepys MB, Booth SE, Tennent GA, Butler PJG, Williams DG (1994) Binding of pentraxins to different nuclear-structures- C-reactive protein binds to small nuclear ribonucleoprotein-particles, serum amyloid-P component binds to chromatin and nucleoli. Clin Exp Immunol 97:152–157CrossRefPubMedPubMedCentralGoogle Scholar
  54. Pritchard DG, Volanakis JE (1985) Slutsky GM and Greenblatt CL C-reactive protein binds leishmanial excreted factors. Proc Soc Exp Biol Med 178(3):500–503CrossRefPubMedGoogle Scholar
  55. Raynes J (1982) Variations in the relative proportions of microheterogeneous forms of plasma glycoproteins in pregnancy and disease. Biomed Pharmacother 36(2):77–86PubMedGoogle Scholar
  56. Richardson MD, Grey CA, Shankland GS (1991) Opsonic effect of C-reactive protein on phagocytosis and intracellular killing of virulent and attenuated strains of Candida albicans by human neutrophils. FEMS Microbiol Immunol 3:341–344CrossRefPubMedGoogle Scholar
  57. Ridker PM (2009) C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 55(2):209–215. doi: 10.1373/clinchem.2008.119214, Epub 2008 Dec 18
  58. Robey FA, Liu T-Y (1981) Limulin – a C-reactive protein from Limulus polyphemus. J Biol Chem 256:969–975PubMedGoogle Scholar
  59. Robey FA, Jones KD, Tanaka T, Liu TY (1984) Binding of C-reactive protein to chromatin and nucleosome core particles: a possible physiological role of C-reactive protein. J Biol Chem 259:7311–7316PubMedGoogle Scholar
  60. Salonen EM, Vatrio T, Hedman K, Vaheri A (1984) Binding of fibronectin by the acute phase reactant C-reactive protein. J Biol Chem 259:1496–1501PubMedGoogle Scholar
  61. Sinha S, Mandal C (1996) Microheterogeneity of C-reactive protein in the sera of fish Labeo rohita induced by metal pollutants. Biochem Biophys Res Commun 226(3):681–687CrossRefPubMedGoogle Scholar
  62. Sinha S, Mandal C, Allen AK, Mandal C (2001) Acute phase response of C-reactive protein of Labeo rohita to aquatic pollutants is accompanied by the appearance of distinct molecular forms. Arch Biochem Biophys 396(2):139–150CrossRefPubMedGoogle Scholar
  63. Srinivasan N, White HE, Emsley J, Wood SP, Pepys MB, Blundell TL (1994) Comparative analyses of pentraxins: Implications for protomer assembly and ligand binding. Structure 2(11):1017–1027CrossRefPubMedGoogle Scholar
  64. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET (2002) Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation 105(5):564–569CrossRefPubMedGoogle Scholar
  65. Tseng J, Mortensen RF (1988) Binding of human C-reactive protein (CRP) to plasma fibronectin occurs via the phosphorylcholine-binding site. Mol Immunol 25:679–686CrossRefPubMedGoogle Scholar
  66. Ulenbruck G, Soelter J, Janssen E, Haupt H (1981) 2 new, additional combining sites of C-reactive protein-lectin specificity of the anti-galactan type and anti-hemocyanin reactivity. Hoppe-Seyler’s Z Physiol Chem 362:1167–1169Google Scholar
  67. Volanakis JE (2001) Human C-reactive protein: expression, structure, and function. Mol Immunol 38:189–197CrossRefPubMedGoogle Scholar
  68. Volanakis JE, Kaplan MH (1971) Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med 136:612–614CrossRefPubMedGoogle Scholar
  69. Volanakis JE, Narkates AJ (1981) Interaction of C-reactive protein with artificial phosphatydilcholine bilayers and complement. J Immunol 126:1820–1825PubMedGoogle Scholar
  70. Volanakis JE, Wirtz KWA (1979) Interaction of C-reactive protein with artificial phosphatydilcholine bilayers. Nature 281:155–157CrossRefPubMedGoogle Scholar
  71. Volanakis JE, Clements WL, Schrohenlohr RE (1978) C-reactive protein: purification by affinity chromatography and physiochemical characterization. J I Methods 23:285–295Google Scholar
  72. Woo P, Korenberg JR, Whitehead AS (1985) Characterization of genomic and complementary DNA sequence of human C-reactive protein, and comparison with the complementary DNA sequence of serum amyloid P component. J Biol Chem 260:13384–13388PubMedGoogle Scholar
  73. Yasojima K, Schwab C, McGeer EG, McGeer PL (2001) Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 158:1039–1051CrossRefPubMedPubMedCentralGoogle Scholar
  74. Ying SC, Gewurz H, Kinoshita CM, Potempa LA, Siegel JN (1989) Identification and partial characterization of multiple native and neoantigenic epitopes of human C-reactive protein by using monoclonal antibodies. J Immunol 143:221–228PubMedGoogle Scholar
  75. Yue CC, Muller-Greven J, Dailey P, Lozanski G, Anderson V, Macintyre S (1996) Identification of a human C-reactive protein binding site in two hepatic carboxylesterases capable of retaining C-reactive protein within the endoplasmic reticulum. J Biol Chem 271:22245–22250CrossRefPubMedGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  • Waliza Ansar
    • 1
  • Shyamasree Ghosh
    • 2
  1. 1.Department of ZoologyBehala CollegeKolkataIndia
  2. 2.National Institute of Science EducationSchool of Biological SciencesBhubaneswarIndia

Personalised recommendations